Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Genetics and HIV-1 Protease Inhibitors

This study has been completed.
Sponsor:
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01388543
First received: June 28, 2011
Last updated: May 17, 2016
Last verified: May 2016